Antithrombotic treatment in atrial fibrillation.
Kalra
L
L
Cardiovascular Division, King's College London School of Medicine, London, UK. lalit.kalra@kcl.ac.uk
Lip
G Y H
GY
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications*; D016903:Drug Monitoring / Q000379:methods; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D018570:Risk Assessment / Q000379:methods; D012648:Self Care; D020521:Stroke / Q000209:etiology / Q000517:prevention & control; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants; D005343:Fibrinolytic Agents